Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | KDM5A | P29375 | 3/20 | 0.39 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.39 |
| ▸ | THRA | P10827 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28547305 | 0.82 | CA12 (0.40) | CA12CA1CA9KDM5APHF8 | |
| SCHEMBL28548289 | 0.81 | S1PR2 (0.33) | CA12CA1CA9THRATHRB | |
| SCHEMBL21826822 | 0.78 | ZDHHC20 (0.38) | CA12CA1CA9KDM5APHF8 | |
| SCHEMBL8088720 | 0.77 | GPR84 (0.36) | GPR84FFAR1 | |
| SCHEMBL28551737 | 0.76 | KDM5A (0.49) | CA12CA1CA9KDM5APHF8 | |
| SCHEMBL7897145 | 0.75 | CA2 (0.42) | CA12CA1CA9GPR84CA2 | |
| SCHEMBL28545692 | 0.75 | KDM5A (0.48) | CA12CA1CA9KDM5APHF8 | |
| SCHEMBL8816793 | 0.75 | GPR84 (0.45) | CA12CA1CA9GPR84CA2 | |
| SCHEMBL29641946 | 0.75 | KDM5A (0.53) | CA12CA1CA9KDM5APHF8 | |
| SCHEMBL25509010 | 0.73 | KDM5A (0.44) | KDM5APHF8KDM4CTHRATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112639050-B | Asymmetrically substituted diamido ammonium dicarboxylic acid salts and their use for antiagglomerating gas hydrates | 科莱恩国际有限公司 | 2022-11-01 | — | — | CN | disclosed |
| EP-3864108-B1 | UNSYMMETRICALLY SUBSTITUTED DICARBOXYLIC ACID DIAMIDO AMMONIUM SALTS AND THEIR USE FOR GAS HYDRATE ANTI-AGGLOMERATION | CLARIANT INT LTD (CH) | 2022-06-15 | — | — | EP | disclosed |
| US-11161804-B2 | Unsymmetrically substituted dicarboxylic acid diamido ammonium salts and their use for gas hydrate anti-agglomeration | CLARIANT INTERNATIONAL LTD. (CH) | 2021-11-02 | — | — | US | disclosed |
| EP-3864108-A1 | UNSYMMETRICALLY SUBSTITUTED DICARBOXYLIC ACID DIAMIDO AMMONIUM SALTS AND THEIR USE FOR GAS HYDRATE ANTI-AGGLOMERATION | Clariant International Ltd (CH) | 2021-08-18 | — | — | EP | disclosed |
| CN-112639050-A | Asymmetrically substituted diamido ammonium dicarboxylic acid salts and their use for antiagglomerating gas hydrates | 科莱恩国际有限公司 | 2021-04-09 | — | — | CN | disclosed |
| US-20200109107-A1 | Unsymmetrically Substituted Dicarboxylic Acid Diamido Ammonium Salts And Their Use For Gas Hydrate Anti-Agglomeration | CLARIANT INTERNATIONAL, LTD. (CH) | 2020-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200109107-A1 | Unsymmetrically Substituted Dicarboxylic Acid Diamido Ammonium Salts And Their Use For Gas Hydrate Anti-Agglomeration | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, SLC9A5, NUP205 | CA12 141/4885CA1 40/4885CA9 93/4885 |
| US-11161804-B2 | Unsymmetrically substituted dicarboxylic acid diamido ammonium salts and their use for gas hydrate anti-agglomeration | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, SLC9A5, NUP205 | CA12 138/4885CA1 40/4885CA9 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.